| Charlene Kay Schmitz, LCSW | |
|
312 3rd St, Center For Mental Health, Havre, MT 59501-3534 | |
| (406) 265-9639 | |
| (406) 265-6771 |
| Full Name | Charlene Kay Schmitz |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 312 3rd St, Havre, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376564575 | NPI | - | NPPES |
| P00692066 C01340 | Other | MT | RAILROAD MEDICARE |
| 0000071493 | Other | MT | BLUE CROSS/SHIELD OF MONT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 590 LCSW (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charlene Kay Schmitz, LCSW Po Box 3089, Center For Mental Health, Great Falls, MT 59403-3089 Ph: (406) 265-9639 | Charlene Kay Schmitz, LCSW 312 3rd St, Center For Mental Health, Havre, MT 59501-3534 Ph: (406) 265-9639 |
News Archive
Withdrawal of life-sustaining support and withholding lifesaving measures (such as CPR) appear to be the primary modes of infant deaths in a neonatal intensive care unit, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The recent ability to peer into the brain of living individuals with a rare type of language dementia, primary progressive aphasia (PPA), provides important new insights into the beginning stages of this disease - which results in language loss - when it is caused by a buildup of a toxic protein found in Alzheimer's disease.
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
A new paper to be published in The Journal of Shoulder and Elbow Surgery evaluates the effect that topical benzoyl peroxide (BPO), with chlorhexidine skin preparation, has on the presence of Propionibacterium acnes cultured at the time of shoulder surgery. The authors hypothesized that adding topical BPO, the active ingredient in Clearasil, to the pre-operative skin preparation would reduce the number of positive P. acnes cultures identified during surgery.
› Verified 2 days ago
William Joe Uhl, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 312 3rd St, Center For Mental Health, Havre, MT 59501 Phone: 406-265-9639 Fax: 406-265-8771 | |
Lindsey Reichelt, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 306 3rd Ave Ste 204, Havre, MT 59501 Phone: 406-229-8100 | |
Sharon Jean Dolph, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1441 11th St W, Havre, MT 59501 Phone: 406-265-9613 Fax: 406-265-4414 | |
Andreya Marie Taylor, LCSW, LISW-CP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 130 4th Ave Apt 4, Havre, MT 59501 Phone: 409-350-8973 | |
Dr. Sue Anne Tanner Workman Pollington, PHD, LCSW, LAC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1023 5th St, Havre, MT 59501 Phone: 406-217-5222 | |
Mr. Arthur Gary Stewart, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 521 4th St, Havre, MT 59501 Phone: 475-308-2048 Fax: 860-826-4995 |